Concepedia

Mari Iida

MI

Statistics

Publications

42

Citations

2.6K

H-Index

29

Active since

1999

Affiliations

University of Wisconsin–Madison(Current)

University of Wisconsin Carbone Cancer Center

Radboud University Nijmegen

City of Hope

University of Chicago

Mari Iida is an author at University of Wisconsin–Madison specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

1999–2024

42

Publications

42

Nuclear EGFR contributes to acquired resistance to cetuximab

C Li, Mari Iida, Emily Dunn et al. · Oncogene · 2009 · 308 citations · Full text

, , +11

AXL Mediates Resistance to Cetuximab Therapy

Toni M. Brand, Mari Iida, Andrew P. Stein et al. · Cancer Research · 2014 · 193 citations · Full text

, , +17

Activation of Multiple ERBB Family Receptors Mediates Glioblastoma Cancer Stem-like Cell Resistance to EGFR-Targeted Inhibition

Paul A. Clark, Mari Iida, Daniel M. Treisman et al. · Neoplasia · 2012 · 139 citations · Full text

, , +17

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab

Emily Dunn, Mari Iida, Rebecca A. Myers et al. · Oncogene · 2010 · 132 citations · Full text

, , +12

AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

Toni M. Brand, Mari Iida, Andrew P. Stein et al. · Clinical Cancer Research · 2015 · 117 citations · Full text

, , +16

1–5 of 42